Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2016 for GlaxoSmithKline plc, €1,055.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
S Witty: trading record in brief
S Witty discloses dealings in GlaxoSmithKline plc to RNS (LSE). In total, 2 filings cover trades dated from 14 July 2016 to 13 October 2016.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 14 October 2016: a share grant of €1,055, in GlaxoSmithKline plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to S Witty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
- 56 shares@ £17.038947.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171057_013001974_20200330143616319_11065-4
- 58 shares@ £16.587652.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718170549_012896749_20200330143558405_13597
2 of 2 declarations